0001171843-17-003747.txt : 20170621 0001171843-17-003747.hdr.sgml : 20170621 20170621161928 ACCESSION NUMBER: 0001171843-17-003747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS PAUL J CENTRAL INDEX KEY: 0001309702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 17923091 MAIL ADDRESS: STREET 1: 61 HARTFORD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94114 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2017-06-20 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001309702 HASTINGS PAUL J C/O PROTEON THERAPEUTICS, INC. 200 WEST STREET WALTHAM MA 02451 1 0 0 0 Stock Option (Right to Buy) 1.30 2017-06-20 4 A 0 6666 0 A 2027-06-19 Common Stock, $0.001 par value 6666 6666 D The options were granted on June 20, 2017 and the shares underlying this option will vest 100% at the earlier of (i) June 20, 2018 and (ii) the Issuer's next annual meeting of stockholders. /s/ George A. Eldridge, attorney-in-fact for Paul J. Hastings 2017-06-21